Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-06

Clinical Trial Update: Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring Wenyang Huoxue Decoction for heart failure following myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wenyang Huoxue Decoction

Snippet

Sponsor: Jun Li | Conditions: Heart Failure, Myocardial Infarction | Phase 2 | Status: UNKNOWN